Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Fertigpen, ATC L03AX13

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 05, 2027 · 231 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Fertigpen, ATC L03AX13

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or minimum guarantee provided. Revenue potential is unclear.

Open-house agreements automatically terminate if a nationally or regionally awarded discount contract for the same subs...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for Glatiramer acetate in pre-filled pen dosage form (ATC L03AX13).
  • Contracts are identical and non-negotiable for all pharmaceutical companies that meet eligibility criteria.
Show full summary

Open-house model for non-exclusive discount agreements on Glatiramer acetate (pre-filled pen, ATC L03AX13) with AOK Bayern. All qualifying pharmaceutical companies can join identical, non-negotiable contracts. Contract period: 1 June 2025 to 31 May 2027, with possible later start. No estimated value provided.

Risks

No estimated value or minimum guarantee provided. Revenue potential is unclear.

Open-house agreements automatically terminate if a nationally or regionally awarded discount contract for the same subs...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutischer Unternehmer).

Administrative

  • Submit signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit signed contract and annex specifying the medicinal products.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; this is an open-house model where all eligible participants are accepted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Glatirameracetat in der Darreichungsform Fertigpen, ATC L03AX13

Single lot covering discount agreements for Glatiramer acetate pre-filled pen. Framework agreement with multiple contractors. Duration 24 months.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No award criteria; this is an open-house model where all eligible participants are accepted.

Deadline

Deadline Apr 05, 2027

Procurement Details

Publication date
15 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
249001-2025

Documents (2)

Similar tenders